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Immunization  of mice  by  intravenous  injection  of relatively low  doses  of sheep 
erythrocytes (SRBC) 1 leads to a  potent  but  evanescent  form of delayed-type hyper- 
sensitivity (DTH)  (1). 4 d after immunization, the injection of the appropriate antigen 
into the footpad of a mouse leads to induration and swelling 24 and 48 h later. By 10- 
14 d  after immunization, similar challenge elicits significantly weaker reactions, or no 
reactions  at  all  (1).  On  the  other  hand,  immunization  with  antigen  emulsified  in 
complete  Freund's  adjuvant  or  administered with  bacilli Calmette-Gu~rrin  (BCG) 
results  in  a  much  longer-lived immunity  of a  similar type  (2).  The  waning  of the 
evanescent  form  of the  DTH  described  above  does  not  appear  to  be  a  result  of 
suppressor cell activity, and  thus  one  form  of DTH  is most  likely mediated by an 
inherently short-lived T  cell (1). 
We  now  report  that  contact  hypersensitivity reactions  (CS),  like  DTH  reactions 
discussed  above,  occur  in  two  forms:  an  evanescent  and  a  long-lived  class.  Skin 
painting  with  a  reactive  form  of  the  immunogen  leads  to  a  long-lived  form  of 
immunity.  On  the other hand,  we  have confirmed  the  findings of Greene et  al.  (3) 
that subcutaneous injections of the immunogen conjugated to peritoneal exudate cells 
(PEC)  lead to a  short-lived form. Again in agreement with Greene et al. (3) we have 
found that intravenous injection of immunogen conjugated to PEC  fails to yield any 
class  of CS,  and  in  fact  leads  to  specific  immunological  unresponsiveness  for  CS 
induced by contact  painting.  However,  if mice which  are immunized  intravenously 
with  hapten-conjugated  PEC,  are pretreated with  cyclophosphamide  (CY),  CS can 
then be elicited. 
In  contrast,  intravenous  injection of hapten-conjugated  epidermal  cells does  not 
require  CY  pretreatment  to  induce  immunity;  nor  does  the  immune  state  rapidly 
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wane. Therefore, immunization  with epidermal cells conjugated with antigen induces 
a class of CS more like the one induced by skin painting than like the one induced by 
injection of  antigen-conjugated PEC.  Thus,  not  only  the  anatomical  site  where 
antigen is first encountered by the immune apparatus, but also the nature of the cells 
that  present the antigen, determine whether a  DTH  response will ensue, as well as 
whether it will be evanescent or long-lasting. 
Materials and Methods 
Animals.  Inbred CBA mice of both sexes, weighing 22-25 g were used in all experiments. 
Only one sex was used in any one experiment. These mice and BALB/c mice were obtained 
from the breeding unit of the Institute of Microbiology, Cracow,  Poland. Guinea pigs were 
purchased from a local supplier in Poland. 
Reagents.  The  following reagents  were  used:  picryl  chloride  (PCL)  (Fluka  AG,  Buchs, 
Switzerland); trinitrobenzene  sulphonic acid (PSA) and oxazolone (OX)  (4-ethoxymethylene- 
2-phenyloxazolone)  (British Drug Houses Ltd., Poole, Dorset, England); [51Cr]sodium chromate 
(Institute for  Nuclear Research,  Warsaw,  Poland); and CY  (VEB,  Jenapharm, Democratic 
Republic of Germany). 
Cells 
MACROPHAGES.  Peritoneal exudates were induced by i.p. injection of 3 ml of thioglycollate 
medium (Difco Laboratories, Detroit, Mich.) or 3 ml Marcol 52 oil (Exxon Corp., New York). 
The cells harvested 4 or 5 d  later, respectively, were  90-95% macrophages and were termed 
PEC throughout. 
TIJVMOCVTES.  Thymuses were removed after exsanguination and were gently teased apart 
between the  frosted  ends of microscope slides  into the  cold  Hanks' balanced salt  solution 
(HBSS). 
EPIDERMAL CELLS.  Epidermal  cells  were  obtained  from  the  tail  skin  by  trypsinization 
according to the method of Scheid et  al.  (4)  with minor modifications. In one experiment, 
epidermal  cells  were  separated  into  fractions  enriched  and  depleted  of  Fc-positive cells. 
Epidermal cells were incubated (37°C, 45  rain) with SRBC coated  with  mouse anti-SRBC 
antibody at a ratio of 10 SRBC:epidermal cells, and then were layered over Ficoll (Pbarmacia 
Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.)-sodium metrizoate (12 parts  14% 
Ficoll 400 +  5 parts 32.8% sodium metrizoate) and centrifuged for 30 rain at 2,000 g. Cells from 
the overlayer and pellet were freed  of erythrocytes by treatment with 0.17 M  NH4CI,  labeled 
with  trinitrophenyl (TNP),  and injected intravenously into CBA  mice.  The pellet  fraction 
contained 18% of the skin cells and was called Fc enriched, whereas the overlayer was called Fc 
depleted. 
ERVTnROCV'rES.  Mouse erythrocytes (MRBC) were collected after injection  of 200 U heparin 
i.v.  per  mouse.  Before  hapten  labeling, the  buffy coat  was  removed.  Chicken erythrocytes 
(CRBC) were a mixture obtained from three donors. SRBC were obtained from a single animal. 
Hapten Labeling of Cells.  All cells  were  washed  several  times  in  HBSS  before  they  were 
labeled with hapten. TNP-substituted erythrocytes were prepared as described by Rittenberg 
and Pratt (5) with minor modifications (6). 20 mg of PSA per 7 ml of cacodylate buffer were 
used to label 1 ml of packed erythrocytes. PSA in HBSS (3 mg/ml) was used to label 5 ×  10  v 
nucleated cells for 10 min at room temperature. OX was dissolved in absolute ethanol (10 mg/ 
ml) and mixed rapidly with 20 ml of EDTA buffer (0.05 M, pH 8.4). The solution was used 
immediately for cell labeling (7). 1 ml of packed MRBC was suspended in 10 ml calcium-free 
HBSS and mixed with 20 ml of OX solution. Nucleated cells were suspended in HBSS at  107/ 
ml and mixed with a double volume of OX solution diluted previously 1  : 1 with EDTA buffer. 
PEC  and thymocytes were  labeled for  10  min at  room  temperature, whereas  MRBC were 
labeled for 30 min. After labeling, cells were washed twice with EDTA buffer (0.05 M, pH 7.5), 
once with  HBSS,  then were  filtered  through  nylon N110  gauze,  and  the  cell  density was 
adjusted to the desired concentration. Viability was assessed by trypan blue dye exclusion and 
ranged  between  70  and  85%. Generally,  ~50%  of  the  cells  were  recovered  after  hapten 
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Antibodies.  CBA  mice  were  injected  three  times  at  weekly  intervals  with  5  ×  10  s  TNP- 
substituted  CRBC  (TNP-CRBC), and  bled out  7 d  after the last  injection. The hemaggluti- 
nation  titer  of the  pooled  sera  was  1:1,024  with  TNP-substituted  SRBC.  Guinea  pigs  were 
injected with  109 MRBC,  108 thymocytes, or 5  ×  108 TNP-CRBC  i.v. at  two occasions 2 wk 
apart  and  bled out 6  d  later.  Anti-MRBC and anti-thymocyte antibody were adsorbed  (1:1) 
with thymocytes or MRBC, respectively, and no cross-reactions were found  in hemagglutina- 
tion. The hemagglutination titers of adsorbed  guinea pig anti-MRBC and anti-TNP sera were 
1:1,024 and  1:512, respectively. Anti-thymocyte serum diluted  1:40 killed  10  v thymocytes per 
ml in the presence of complement. Sera were heat inactivated at 56°C for 30 rain before being 
used. 
Preparation of (Fab')~  Fragments.  The  IgG-containing  fraction  of anti-TNP  antibody  in 
guinea pig immune serum was precipitated three times with 33% saturated  NH4SO4.  Pepsin 
digestion was performed as described elsewhere (8). The digested globulin fraction was dialyzed 
into 0.1  M  phosphate buffer, pH 6.8, and was applied to a 2- X 60-cm Sephadex G-100 column 
(Pharmacia  Fine Chemicals, Div. of Pharmacia,  Inc.). Protein concentration  in each fraction 
was  estimated  spectrophotometrically  at  280  nm,  and  the  hemagglutination  titer  of each 
fraction was determined.  Fractions showing the peak values were pooled and concentrated by 
ultrafiltration. The hemagglutination titer of the (Fab')2 preparation  was  1:320. 
Coating of TNP-substituted Cells with Antibody.  TNP-labeled cells were incubated for 45 min at 
room temperature with antibody directed against the hapten or the cell to which the TNP was 
attached.  As  a  routine  procedure,  1 ×  108 cells were  incubated  with  1 ml  of corresponding 
antibody diluted  1:10. 
Feeding of  PEC with Antzgen.  Thioglycollate-induced PEC were incubated in vitro for 45 min 
at  37°C in the presence of ~lCr-labeled TNP-substituted  MRBC  (TNP-MRBC)  coated with 
either  anti-MRBC  or  anti-TNP  antibody,  at  a  PEC  to  erythrocyte  ratio  of  1:10.  After 
incubation,  the mixture was washed,  nonphagocytosed  erythrocytes  were lysed with  0.17  M 
NH4C1  buffer,  the remaining cells were washed  several times in  HBSS, counted  in  well-type 
gamma counter (Beckman Instruments,  Munich, Federal Republic of Germany)  and  injected 
intravenously into recipients within  1 h. 
Sensitization to PCL or OX. Mice were sensitized by applying 0.15 ml of a  7% solution of PCL 
or 3% OX in absolute ethanol  to the skin of the clipped abdomen.  4  d  later, unless otherwise 
state, control ear thickness was measured  with an engineer's micrometer (Moore and Wright, 
Sheffield, England), then both sides of both ears were painted with a  1% solution of homologous 
contact  reagent dissolved in olive oil, and the increment of ear thickness was measured  24 h 
later. Results were expressed as the mean +  SD in units of 10 -3 cm (9). 
Induction of CS Immunity or Unresponsiveness  by Cell-bound  Hapten.  CBA mice were injected with 
hapten-substituted  syngeneic or allogeneic cells intravenously,  subcutaneously,  intraperitone- 
ally, or into the footpad.  Routinely (unless otherwise state),  3  ×  10  6 epidermal cells, 5  X  10  6 
PEC, 5 ×  10 7 thymocytes (Thy), or 109 MRBC were injected. Some mice were treated with 50 
mg/kg CY i.p. 24 h  before injection of hapten-substituted  cells. 
Mice were tested for CS 7 d  after the cell injection (unless otherwise stated),  because it was 
found  that  they  develop  peak  responses  at  this  time.  Mice  found  to  be  unresponsive  were 
contact  painted  with corresponding  or unrelated  skin sensitizer and  were tested  4  d  later  to 
ascertain if the unresponsiveness was the result of specific tolerance. Experiments in which ear 
swelling was measured at  12, 24, and 48 h  showed that  the peak response occurred 24 h  after 
challenge  in  both  skin-sensitized  mice  and  those  immunized  with  hapten-conjugated  cells. 
Thus, only 24-h responses are shown in the Tables. 
As  a  result  of normal  inter-experimental  variability  of ear  swelling  induced  by  contact 
painting  in both sensitized and  nonsensitized  normal  controls,  the results were shown  as the 
percentage of CS responses of contact-sensitized  positive controls when data was summarized 
from  several  experiments.  These  were  calculated  for  each  individual  experimental  group 
according to the formula:  the percentage of CS response =  (A -  C)/(B -  C)  x  100;  where A 
refers to  the 24-h  increment  in ear thickness  in an  experimental  group  that  was  immunized 
with conjugated cells; B refers to the 24-h increment in ear thickness in a positive control group 
which was immunized by contact skin painting; and C refers to the nonspecific 24-h increment 
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Results 
Induction of Immunity  or Unresponsiveness by PEC-bound Hapten,  According to the Route of 
Injection (Table I).  Hapten-conjugated PEC injected intravenously or intraperitone- 
ally failed to induce CS, but when similar numbers of TNP-substituted (TNP-PEC) 
or OX-substituted PEC were injected subcutaneously (into the scapular region or into 
the footpads) mice had significant CS 1 wk later. The CS induced in this manner was 
hapten-specific  (results  not  shown).  Oil-induced syngeneic TNP-PEC  were  more 
immunogenic than thioglycollate-induced cells (group A  vs.  B)  and allogneic conju- 
gated PECI  did not induce CS  (group C). TNP-substituted Thy (TNP-Thy) used in 
similar numbers as PEC (group D) induced insignificant  CS, whereas higher numbers 
(group E)  were moderately immunogenic. Thus, the  induction of CS  with  hapten- 
conjugated PEC depends largely on the route of injection and the use of syngeneic 
cells. 
Induction  of Specific  Unresponsiveness by  Cell-bound Hapten.  Experiments  were  con- 
ducted to see if the failure to induce CS by intravenous or intraperitoneal injection of 
hapten-conjugated cells was a  result of the induction of tolerance. The results of such 
an experiment  (Table II)  show  that  mice injected intravenously with syngeneic or 
allogeneic PEC,  Thy or  erythrocytes  labeled with  TNP  or  OX  could  not  be  skin 
sensitized with appropriate sensitizer 7 d after injection  of these cells. Unresponsiveness 
was specific because only responses to the homologous hapten were inhibited (Table 
II). However, suppression was less significant when OX was used to label the cells. 
Thus, neither the source of cells nor their genetic makeup was relevant to inducing 
specific unresponsiveness. 
Effect of CY on the Induction of CS (Table III).  Treatment of mice with CY (50 mg/ 
kg)  24  h  before  the  cell  injection  allowed  animals  injected  intravenously with 
syngeneic, but  not  allogeneic TNP-PEC  to  develop  significant CS  reactions when 
tested 7 d later (group A). However, CY pretreatment failed to induce CS when either 
syngeneic or  allogeneic TNP-Thy  or  TNP-MRBC  were  injected  intravenously in 
similar numbers as macrophages  (group B), although syngeneic cells used in higher 
TABLE  I 
Induction of CS in CBA Mice by TNP-PEC* 
Route of injection 
Cell 
Group  donor  Cells injected 
strain  Intravenous  Intraperi- 
toneal 
Subcutaneous 
Footpad  Scapular 
A  CBA  TNP-PEC (oil)  6.4 + 3.8~  10.7  + 4.5  60.4  +  10.8  70.5  -  12.5 
B  CBA  TNP-PEC (thioglycollate)  7.2 +- 2.7  12.3 + 6.3  48.2  "4- 3.9  55.4 +  13.8 
C  BALB/c TNP-PEC (thioglycollate)  10.2 + 5.3  8.8 +- 3.4  12.5  +- 1.4  10.8 +-- 7.3 
D  CBA  TNP-Thy(5X 106  )  8.4---2.0  11.2+5.1  8.5+3.7  10.4+-5.7 
E  CBA  TNP-Thy (5 X l07)  0.8 +- 1.0  8.4 + 3.2  24.0  --- 5.8  28.5 +- 3.5 
F  CBA  OX-PEC (oil)  3.0 +- 2.5  ND  66.7 +  10.9  75.0  -+ 17.8 
ND, not done. 
* Mineral oil-  or thioglycollate-induced  hapten-substituted PEC (5 ×  l0  n) or thymocytes were injected by 
various routes and 7 d later, mice were tested for CS. 
:~ Results are expressed as the percentage of CS response _  SD of contact skin-sensitized  positive controls. 
The Table shows the combined results of four independent experiments in .which each experimental 
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TAm.E  II 
Induction of Tolerance in CBA Mice by Injection of TNP- or OX-conjugated Cells* 
Cell donor 
Group  strain  Cells injected 
CS 7 d after cells injected:l:  CS 11 d  after cells injected 
Elicited  Elicited by  Elicited by OX 
PCL 4 d after  4 d  after OX 
by  PCL painting:~  painting:~ 
A  CBA  TNP-MRBC  PCL  10.7 4- 5.6§  20.1  ±  5.3  98.4 4- 6.0 
B  CBA  TNP-Thy  PCL  8.5 ±  6.4  12.0 ±  3.8  87.5 4- 7.6 
C  CBA  TNP-PEC  PCL  6.6 ±  3.4  10.3 ±  4.7  92.4 ±  8.4 
D  BALB/c  TNP-MRBC  PCL  12.3 ±  3.7  8.4 ±  3.3  110.1  4-  12.5 
E  BALB/c  TNP-Thy  PCL  10.8 4- 5.0  11.1 ±  2.2  98.0 4- 4.2 
F  BALB/c  TNP-PEC  PCL  4.9 ±  5.1  9.1  ±  2.0  102.3  ±  10.7 
G  CBA  OX-Thy  OX  10.5 +  3.5  92.8 4-  10.5  20.4 +- 8.3 
H  CBA  OX-MRBC  OX  10.6 ±  2.9  106.0 4- 9.9  22.5 ±  7. l 
* CBA mice were injected  intravenously with syngeneic (CBA)  or allogeneic  (BALB/c)  cells  (109 TNP- 
MRBC, 5 X  107 TNP-Thy, or 5 X  106 TNP-PEC. 
Animals were tested for CS after 7 d or were sensitized by skin painting with corresponding or unrelated 
reactive hapten at day 7 and tested for CS 4 d later. 
§ Results are expressed as the percentage of CS response +  SD of contact skin-sensitive positive controls. 
The Table shows the combined results of seven independent experiments in which each experimental 
group consisted of five or six animals. 
TABLE  III 
Effect of CY on the Induction of CS in CBA Mice by TNP-conjugated Cells* 
Cell donor  CS at  7 d  in CY- 
Group  strain  Cells injected  CS at  7 d  injected mice 
A  CBA  TNP-PEC  (5 x  106)  18.3 +  4.5~:  60.8 ±  10.5 
B  CBA  TNP-Thy (5 x  106)  9.4 ___ 6.0  18.3 +  4.7 
C  CBA  TNP-Thy  (5 X  10 7)  10.5 __ 3.5  31.2 +  7.5 
D  CBA  TNP-MRBC (108)  2.5 ±  2.0  10.5 ±  4.7 
E  CBA  TNP-MRBC (109)  3.0 ±  2.5  20.0 ±  5.8 
F  BALB/c  TNP-PEC (5 x  106)  7.5 +  3.3  15.0 ±  3.2 
G  BALB/c  TNP-Thy (5 x  107)  13.6 ±  7.4  16.7 4- 8.2 
H  BALB/c  TNP-MRBC (109)  12.5 +  3.9  12.5 __ 7.4 
*  TNP-substituted syngeneic or atlogeneic cells were injected intravenously into normal or 
CY-treated animals (50 mg/kg, 24 h  before cell injection) and CS was tested 7 d  later. 
Results are expressed as the percentage of CS responses +  SD of contact skin-sensitized 
positive controls. The Table shows the combined results from three independent experi- 
ments in which each experimental group consisted of" five or six animals. 
numbers  induced  some  CS  in CY-pretreated  mice  (groups  C,  D, and  E).  The  CS  was 
specific in that  no  increase  in ear  thickness  occurred  after challenge  with  OX,  a  non- 
cross-reacting  hapten  (Results  not  shown.).  Thus,  CY-sensitive  regulatory  cells  were 
involved  in  the  induction  of tolerance  by  intravenous  injection  of hapten-conjugated 
syngeneic  cells. 
Influence  of Antibody on the Induction  of CS by Cell-bound  TNP (Table IV).  Injection  of 
TNP-substituted  cells intravenously  does not  cause  the development  of CS,  but  when 
the TNP-substituted  cells were  treated  with  antibody  directed  against  TNP  or against 
the cell to which  the TNP  was attached,  significant  CS could  be induced.  The  reaction 
induced  by  antibody-treated  TNP-substituted  cells  was  specific  in  that  no  responses W.  PTAK,  D.  ROZYCKA,  P.  W.  ASKENASE, AND  R.  K.  GERSHON 
TABLE IV 
Influence of Antibody on the Induction of CS by TNP-conjugated Cells* 
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Cell donor  Cells injected 
strain  intravenously 
Treatment of injected cells~ 
Anti-carrier  Anti-TNP  Anti-TNP 
No antibody  antibody  antibody  (Fab')2 
CBA  TNP-MRBC  3.5 +- 2.0§  48.5  -+  10.3  54.5 ±  7.4  5.0 ±  3.5 
CBA  TNP-Thy  7.0±3.5  57.2±  11.5  67.3±  10.8  12.3±7.1 
CBA  TNP-PEC  10.0 ±  7.1  ND  70.5 +  12.6  11.4 +  3.9 
BALB/c  TNP-MRBC  5.3 +  2.7  60.5 ±  10.4  52.6  ±  7.4  3.8 ±  3.2 
BALB/c  TNP-Thy  5.8 ±  0.9  55.4 +  7.5  58.2  +  5.3  10.1 +  5.4 
ND, not done. 
* CBA mice were injected  intravenously with TNP-substituted syngeneic or allogeneic cells 
(5 X l06 PEC, 5 X  10  7 Thy, or 109 MRBC) and were tested for CS 7 d later~ 
:~ In  some  experiments, cells were  treated before  injection  with anti-carrier or  anti-TNP 
antibody, or with anti-TNP (Fab')2 fragments. 
§ Results  are expressed  as the percentage of CS responses  ±  SD of contact skin-sensitized 
positive controls. The Table shows the combined results of three independent experiments 
in which each experimental group consisted of five to seven animals. 
TABLE  V 
Induction of CS by PEC That Had Phagocytosed Opsonized TNP-conjugated 
Erythrocytes 
In vitro cell combination before intravenous injection*  CS at  7 d 
5 ×  106 PEC + anti-TNP antibody-coated TNP-MRBC (2.8 
x  106) 
5 x  106  PEC +  anti-MRBC antibody-coated MRBC  (1.9 
x  106) 
5 x  10  6 TNP-PEC +  none§ 
4.3 + 0.89~: 
4.6 ± O.56 
1.5 ± 0.31 
Positive control (7% PCL sensitization) 
Negative control (unsensitized) 
7.8 ±  1.23 
1.4 +  0.28 
* Thioglycollate-induced macrophages were  incubated  in  vitro  with  ~lCr-labeled 
TNP-MRBC  (100 #Ci/0A  ml packed cells) coated with guinea pig anti-TNP or 
anti-MRBC antibody. PEC were freed of excess erythrocytes and injected intrave- 
nously into syngeneic  recipients.  The numbers of ingested erythrocytes,  which are 
indicated  within  parenthesis,  were  estimated  from  PEC-associated  radioactive 
counts. 
:~ Results are expressed in units of 10 -3 cm + SD. Each experimental group consisted 
of 6-10 animals. 
§ PEC labeled directly with TNP were used as control cells. 
to OX  were noted (Results not shown.). Whereas, TNP-PEC  injected subcutaneously, 
or  TNP-substituted  cells  injected  into  CY-treated  animals,  only  induced  CS  if 
syngeneic  with  the  recipient,  antibody  treatment  allowed  syngeneic  or  allogeneic 
(BALB/c)  cells  to  induce  CS.  Anti-TNP  antibody  raised  in  guinea  pigs  or  mice 
(results not shown) facilitated the development of CS to the same degree. The integrity 
of the  antibody  molecule  was  essential  because  (Fab')2  fragments were  nonactive. 
Thus,  the  Fc  fragment  was  critical,  presumably  by  enabling  macrophages  in  the 
immunized  host to engulf the injected cells. 
Induction  of CS by PEC that Phagocytosed  TNP-substituted Cells  (Table  V).  When  PEC 
were  combined  in  vitro  with  TNP-MRBC  which  were  complexed  with  antibody 368  EVANESCENT VS.  LONG-LASTING CONTACT SENSITIVITY 
TABLE  VI 
Induction of CS in CBA Mice by Hapten-conjugated Epidermal Cells 
Cell donor 
strain  Cells injected  Route of injection*  CS at  7 d:]: 
CBA  TNP-epidermal cells  Subcutaneous  6.4 ±  1.20 
CBA  TNP-epidermal cells  Intraperitoneal  5.9 ± 0.36 
CBA  TNP-epidermal cells  Intravenous  5.9 + 0.83 
CBA  Positive control  (7% PCL sensitization)  --  8.3 ±  1.27 
CBA  Negative control (unsensitized)  --  1.2 ±  0.34 
BALB/c  TNP-epidermal cells  Intravenous  1.7 +  0.30 
BALB/c  Positive control (7% PCL sensitization)  --  6.7 ±  1.02 
BALB/c  Negative control  --  1.3 + 0.25 
CBA  OX-epidermal cells  Intravenous  6.7 +  1.24 
CBA  Positive control (3% OX sensitization)  --  10.8 ±  2.05 
CBA  Negative control (unsensitized)  --  2.0 ±  0.56 
CBA  TNP-PEC (5 ×  10  n)  Intravenous  1.9 +  0.56 
CBA  TNP-epidermal cells (4 X  10  6)  Intravenous  7.8 +  1.04 
CBA  TNP-PEC (5 ×  106) + 
TNP-epidermal cells (4 X l0  s)  Intravenous  6.1 +  1.86 
CBA  Positive control (7% PCL sensitization)  --  9.8 +  1.84 
CBA  Negative control (unsensitized)  --  2.9 ±  1.84 
* 3  ×  l0  6 TNP- or OK-epidermal cells, syngeneic  or allogeneic  with CBA recipients  were  injected via 
different  routes, and animals were tested  7 d later for CS. 
:~ Results  are expressed  as increases in ear thickness  in units  of 10  -3 cm -  SD.  Each experimental group 
consisted of six to eight animals. 
directed  against  TNP  or  MRBC,  and  were  then  freed  of erythrocytes  and  injected 
invtravenously,  they  induced  a  significant  level of CS.  Thus,  there  is  a  substantial 
difference between PEC that were conjugated directly with TNP,  and those that  had 
ingested  TNP  antigen;  only  the  latter  were  able  to  induce  CS  upon  intravenous 
injection.  These results  also support  the conclusion  that  antibody  treatments  (Table 
IV)  allow induction of CS by promoting  phagocytosis of the antigen. 
Induction of CS by Hapten Bound to Epidermal Cells (Table  VI).  In contrast  to the other 
cell types conjugated with hapten  that,  when  injected intravenously,  induced  a  state 
of unresponsiveness,  TNP-  or OX-conjugated  epidermal  cells injected  intravenously 
induced  CS.  Conjugated  epidermal  cells  had  to  be  syngeneic  with  the  recipient  to 
induce CS. TNP-conjugated  epidermal  cells  (TNP-epidermal  cells) were also  immu- 
nogenic  when  injected  intraperitoneally  or subcutaneously.  Furthermore,  TNP-epi- 
dermal  ceils induced  CS  even when  injected  intravenously  with  doses  of TNP-PEC 
that  induce tolerance.  Thus,  hapten-conjugated  epidermal cells failed to suppress  CS 
and  uniformly  induced  CS,  independent  of the  route  of injection,  and  even  when 
coadministered with doses of TNP-PEC  that by themselves induced unresponsiveness. 
Epidermal  cells  were  fractionated  by  taking  advantage  of the  fact  that  some  of 
these cells (i.e., Langerhans  cells [10])  have Fc receptors  that  promote adherence  and 
rosette  formation.  Accordingly,  epidermal  cells  were  incubated  with  SRBC  coated 
with  mouse  antibody  and  then  were  centrifuged  in  a  Ficoll-Hypaque  (Winthrop 
Laboratories,  New  York)  gradient.  The  pellet contained  18%  of the epidermal  cells 
and  was called Fc enriched,  whereas  the remaining  cells at  the  interface were called W.  PTAK,  D.  ROZYCKA,  P.  W.  ASKENASE,  AND  R.  K.  GERSHON 
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Induction of CS by TNP-conjugated Epidermal Cells Fractionated According to Fc Receptors* 
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Number  Number  Cells injected  Fraction  CS at 7 d~:  of cells  of mice 
TNP-epidermal cells  Fc depleted  1  3.3 ±  0.89  5 
TNP-epidermal cells  Fc depleted  3  4.1 ±  1.2  4 
TNP-epidermal cells  Fc enriched  1  6.7 +  1.3  3 
Positive control (7% PCL sensitization)  --  --  8.7 ±  1.63  5 
Negative control (unsensitized)  --  --  2.0 ±  0.58  4 
* Epidermal cells were combined with antibody-coated erythrocytes and separated  via density-gradient 
centrifugation into a pellet (Fc enriched) and an interface (Fc depleted) fraction. Subsequently, eryth- 
rocytes were lysed and remaining cells were conjugated with TNP and injected intravenously. 
z~ Results are expressed as increase in ear thickness in units of 10  -3 cm ±  SD. 
TABLE  VIII 
Passive Transfer of CS Induced by Different Schedules of Sensitization* 
Induction of CS  Route of induction 
CS at day 7 
Actively sensi-  Passive transfer 
tized donors  recipients 
TNP-PEC  Subcutaneous  6.0 +  1.20  4.1 ±  0.55 
TNP-PEC  Intravenous  1.7 ±  0.56  1.6 ±  0.27 
TNP-epidermal cells  Intravenous  5.9 ±  1.07  4.2 ±  0.34 
Anti-TNP antibody-coated TNP-Thy  Intravenous  5.8 ±  0.86  4.4 ±  0.12 
Positive control (7% PCL sensitization)  --  8.5 ±  1.36  6.1 ±  1.07 
Negative control (unsensitized)  --  1.4 +_ 0.33  1.3 ±  0.40 
* CBA mice were injected subcutaneously or intravenously with 5 ×  106 TNP-PEC, with 3 ×  106 TNP- 
epidermal cells, or intravenously with TNP-Thy complexed with anti-TNP antibody. Positive control 
animals were contact skin painted with 7% PCL. Lymph node and spleen cells were harvested 7 d after 
immunization (except  when PCL was used, cells were collected at day 4) and injected intravenously into 
normal recipients (4 ×  107 cells). Recipient animals were challenged immediately after transfer. Results 
are expressed in units 10  -a cm +  SD. Each experimental group consisted of five or six animals. 
Fc depleted.  After erythrocyte lysis, both populations  were conjugated  with TNP  and 
were  used to  induce  CS  by intravenous  injection.  The  results of such an experiment 
(Table VII)  show that Fc-enriched epidermal  cells were more efficient at inducing CS 
than  were  Fc-depleted  epidermal  cells.  Thus,  1  ×  106  Fc-depleted  epidermal  cells 
induced  less  than  one-third  of  the  CS  responses  induced  by  1  X  106  Fc-enriched 
epidermal  cells.  All the immunizing  capacity  of the epidermal  cells could  be obliter- 
ated  by  treatment  with  Ia  antisera  kindly  donated  by  Dr.  Donal  Murphy  of Yale 
University School of Medicine,  New  Haven,  Conn.  (Results not  shown.). 
Passive  Transfer of CS Induced by Different  Schedules.  The experiments  presented above 
showed  that  a  similar CS  could be induced  by skin painting  with  PCL,  by subcuta- 
neous  injection of TNP-PEC,  by intravenous  injection of TNP-Thy  complexed  with 
antibody,  and  by  intravenous  injection  of  TNP-conjugated  epidermal  cells.  To 
confirm  that  in all cases we were dealing  with a  simi|ar cell-mediated  phenomenon, 
adoptive  transfer experiments  were  performed.  As shown  in Table  VIII,  all  of these 
modes of induction  of CS provided  sensitized cells which could transfer the ability to 370  EVANESCENT VS.  LONG-LASTING CONTACT  SENSITIVITY 
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Fro.  1.  On day 0, CBA mice were skin painted with 7% PCL (O) or injected with TNP-substituted 
cells (5 X 10  6 TNP-PEC subcutaneously [[2]], 3 X 10  s TNP-epidermal cells intravenously [0], or 5 
X  10  7  TNP-Thy complexes with anti-TNP antibody [A]). At different times thereafter, separate 
groups of animals were challenged with PCL and the ear skin swelling results were expressed in 
units of 10  -acm. Each experimental group consisted  of five or six animals. The hatched area shows 
the range of nonspecific  ear swelling  in nonsensitized  animals. 
mount specific CS reactions to naive recipients, thus showing that a similar mechanism 
was involved in all cases. 
Time-Course of Elicited  CS Induced by  Different Modes of Immunization  (Fig.  1).  CS 
reactions developed within 3-4 d  in PCL contact skin-sensitized animals. By day 5 
after PCL painting, maximal CS was elicited, and was equally elicitable over the next 
10 d. In contrast, CS induced by TNP-PEC injected subcutaneously,  or by intravenous 
TNP-Thy coated with anti-TNP antibody, was not maximal until 6-8 d,  and then 
progressively declined; approaching responses in nonimmune animals by day  15. On 
the o.ther hand, although CS  induced by injection of TNP-epidermal cells also did 
not reach a  maximum until day 6-8, they did not decline and therefore resembled in 
their lack of evanescence the  CS  induced by contact  skin  painting. Thus, contact 
painting or injection of TNP-epidermal cells induced CS that was long-lived, whereas 
TNP-PEC, or antibody-coated TNP-Thy, induced CS that was evanescent. 
Discussion 
In  this  study,  we  have  described  three  major  outcomes  of  immunization with 
various  forms  of  TNP:  the  induction of specific  immunological unresponsiveness 
(tolerance)  for CS,  the  induction of a  short-lived or evanescent form  of CS,  or  the 
induction of a  long-lived form of CS. 
The  first  outcome,  the  induction of specific  immunological unresponsiveness, is 
probably the result of educating a  net excess of suppressor cells that inhibits animals 
from  making  a  CS  immune response,  and  also  makes  them  resistant  to  further 
immunization. As has been noted previously (3,  11),  this occurs when initial immu- 
nization with TNP-conjugated cells occurs in the spleen via intravenous injection of 
hapten-conjugated ceils. There is no requirement for major histocompatibility com- 
plex  (MHC)  identity between  the  haptenated  cells  and  the  host  for  this  form  of 
specific immunosuppression to occur, and presentation need not be on macrophages. 
However,  we  have  found  two  ways  to  overcome  this  suppression:  (a)  allowing W.  PTAK, D.  ROZYCKA, P.  W.  ASKENASE, AND R.  K. GERSHON  371 
phagocytosis of antigen to occur or (b) by using TNP-conjugated epidermal cells (see 
below). 
The second outcome, induction of evanescent CS with an early peak followed by a 
rapid  decline, occurs when  the balance between suppression  and  helpers is skewed 
toward the latter situation by reduced activation of the suppressor circuit. There are 
three major ways to favor this skewing: (a) Pretreat the animals with a low dose of CY 
before their initial  contact with  antigen.  CY,  in  the dose used, has been shown  to 
inhibit cells in the suppressor T-cell circuit (11,  12). Our results in this case contrast 
with the findings of Miller et al. (13).  Using a different hapten (dinitrophenyl), these 
authors found that pretreatment with CY at a much higher dose than we used (200 
mg/kg)  did not allow intravenously injected haptenated cells to induce immunity. 
The many differences between their experimental protocol and ours makes it difficult 
to  identify the  variable(s)  that  might  account  for  the  different  results.  However, 
because  we  (Table  III),  in  agreement  with  Greene  et  al.  (3),  have  noted  that 
haptenated PEC are more immunogenic when suppression is avoided than are other 
types of haptenated cells, and because Miller et al.  (13) used haptenated spleen cells 
in  lieu  of PEC,  this  might  be  the  crucial  difference.  (b)  Another  way  to  reduce 
activation of the suppressor circuit  is to pretreat  the haptenated cells with  passive 
antibody  against  either  the  hapten  or  the  cell  carrier.  There  are  several  possible 
explanations  for  this  phenomenon.  (i)  Antibody  may  act  by  inducing  increased 
phagocytosis of antigen because removal of the Fc piece from the antibody prevents 
it from fulfilling its role in inhibiting suppression, and feeding macrophages antigen 
before using them as immunogens also blocks their suppressor inducing qualities after 
intravenous injection. Once the antigen has undergone phagocytosis by macrophages, 
the  antigen  may be  processed  in  a  way  which  inhibits  its  ability  to  activate  the 
suppressor circuit (perhaps as a result of antigen degradation as the work of Steinman 
and Cohn [14] has suggested) or favors induction of T  cells which elicit DTH, as the 
work of Zembala et al. (15) has suggested. The conclusion that the host is processing 
antigen is supported by the observation that antibody coating of the TNP-conjugated 
cells is the only mode of sensitization in which TNP does not have to be syngeneic 
with  the  host  to  induce  immunity.  Presumably,  after phagocytosis  the  antigen  is 
presented  to  the  immune  system  in  association  with  the  major  histocompatibility 
determinants  of the  host's  antigen-presenting  cells.  (ii)  Antibody  may  alter  the 
distribution  of antigen within  the  lymphoid organs  so that  immunogenicity is  en- 
hanced  and/or  suppression  reduced.  An  example  of the  latter  is  the  retention  of 
antigen-antibody complexes in the germinal center region of lymphoid organs. Chen 
et al.  (16), using horseradish peroxidase (HRP) as a  marker, have shown that small 
amounts  of HRP-anti-HRP  immune  complexes  formed  in  antigen  excess  escape 
phagocytosis and  instead  associate with  the cell surface of nonphagocytic follicular 
dendritic cells~ In this regard it is important to note that we have found that the mQst 
effective  antigen  presentation  is  performed  by  cells  that  are  weakly  phagocytic 
(Langerhans cells) or nonphagocytic (splenic dendritic cells, vide lhfra).  (c) A third way 
of eliciting  short-lived  CS  is  by  injecting  the  antigen-conjugated  cells,  that  are 
predominantly macrophages,  in  such  a  way  that  primary  immunization  occurs in 
peripheral  lymph  nodes  (3).  This  technique  probably  also  works  via  bypassing 
suppression because it  is  well  known  that  spleen-localizing T  cells are  much  more 
likely to induce or act as suppressor cells than are cells that localize in the lymph node 
(17). 372  EVANESCENT VS.  LONG-LASTING CONTACT SENSITIVITY 
As noted by Greene et al. (3) there is a clear-cut hierarchy in the ability of different 
types of cells  to  immunize under  those conditions  which  bypass suppression;  PEC 
being significantly superior to Thy which  are somewhat better than erythrocytes. It 
is unclear whether CY or antibody treatment blocks the suppression elicited by TNP- 
conjugated allogeneic cells, because MHC-incompatible cells fail to immunize. Thus, 
no reaction would be detected even if suppression had been alleviated. 
The third outcome which may occur after immunization with TNP is the induction 
of a  relatively long-lived form of immunity. This occurs after skin painting or more 
interestingly,  when  haptenated  epidermal  cells  are  injected  intravenously.  Under 
these circumstances there is no need for blockage of the suppressor circuit for immunity 
to  be  seen.  Whether  the  responses  induced  by  this  mechanism  would  be  further 
augmented if suppression were to be reduced is now being tested. 
The cell type(s)  in  the skin which  are responsible for this potent  form of antigen 
presentation are most likely Langerhans cells, because many of them appear to have 
Fc receptors (10).  That the apparently Fc-negative skin cells can also induce this type 
of immunity, although less well than the Fc-positive fraction of cells, may be a result 
of contamination of the Fc-negative fraction, or skin cells themselves may have the 
ability to present hapten. This latter possibility is rendered unlikely because we have 
found  that  the  epidermal  cell  type  responsible  for  inducing  long-lived  CS  bears 
surface antigens coded by the I region of the MHC. Tamaki et al.  (18)  and Rowden 
et al.  (19)  have noted that essentially all Ia-positive epidermal cells are Langerhans 
cells.  We are presently attempting to see which  I-subregion antigen(s)  are involved, 
and preliminary results are in agreement with the finding of Tamaki et al.  (18)  and 
Rowden et al. (19) because both I-A and I-E/C antisera can eliminate the immunizing 
potential of the skin cells.  Perhaps the most interesting  question  this work raises is: 
Why antigen presented on epidermal cells (most likely on Langerhans cells) induces 
such a different form of immunity than does antigen presented on peritoneal exudate 
macrophages? Several possible answers to this question come to mind: 
(a) Within  the PEC population  there is a  cell with an inducing quality similar to 
Langerhans cells but that  their activity is not seen because of the fact that they are 
present  only in  very small  numbers.  The particular  type of cells we have in  mind 
would  be  a  minimally phagocytic  macrophage-like cell  with  cell  surface  antigens, 
coded for in the I region of the MHC (20,  21). Thus, we are trying to concentrate Ia- 
positive cells  from  various  anatomical  compartments to  see  if they have the  same 
inducing qualities as do Langerhans cells. 
One such cell is the splenic dendritic cell described by Steinman et al.  (22).  These 
cells are adherent and Ia positive, but lack Fc receptors and constitute < 1% of splenic 
cells.  Preliminary  results  indicate  that  enriched,  TNP-conjugated  splenic  dendritic 
cells are able to function as potent antigen-presenting cells that can mimic Langerhans 
cells  in  their  capacity  to  induce  CS,  even  when  injected  intravenously,  whereas 
enriched Fc-positive splenic macrophages that are conjugated with TNP mimic PEC 
macrophages in their inability to induce CS (W. Ptak and R. Steinman. Unpublished 
Results.). 
(b)  It is also possible that  not  all Ia-positive cells are the same, and  that  the  Ia- 
positive cells  in  the  skin  will  be  different  from  Ia-positive antigen-presenting  cells 
which are found in other anatomical compartments. If this proves to be the case, it 
would  then  be interesting and  important  to see if non-skin cells can be induced  to W.  PTAK,  D.  ROZYCKA,  P.  W.  ASKENASE,  AND  R.  K.  GERSHON  373 
behave like skin cells by things other than the dermal-epidermal microenvironment. 
In particular, we have preliminary evidence that  macrophages, stimulated  by adju- 
vants that contain mycobacteria can acquire the immunity-inducing capacities of skin 
cells. The notion that this idea might be feasible, stems from the observations that (i) 
immunization with complete Freund's adjuvant  leads to a  long-lived immunity  (2) 
and  (ii)  the  studies  of delayed  type  hypersensitivity  by  Mackaness  et  al.  (2)  and 
Lagrange and Mackaness (23)  which indicate that the adjuvant effect of BCG leads 
to the induction of a set of cells which produce additive effects when mixed with cells 
immunized to express evanescent DTH. Thus, the questions  are:  Are all Ia-positive 
antigen-presenting cells the same? If not, what are the differences, and what experi- 
mental techniques are available to help us understand the mechanism by which some 
of these cells become superior inducers of a CS response? 
It  is  also  important  to  determine  why  some modes  of antigen  presentation  can 
induce  immunity  without  the  need  for  inhibition  or  bypassing  of the  suppressor 
circuit.  Because TNP-epidermal cells are able to induce CS when  injected  intrave- 
nously  mixed  with  TNP-PEC,  this  implies  that  Langerhans  cells  can  effectively 
present antigen in the presence of suppression, whereas immunity-inducing, antigen- 
presenting cells in PEC cannot. This might suggest that Langerhans cells are able to 
activate effector T  cells that  are relatively resistant  to suppression, or alternatively, 
that the specialness of these antigen-presenting cells is their inability to interact with 
the cells of the suppressor circuit. 
In any case, it is quite interesting to note that CS comes in the same two forms as 
other forms of DTH and that the type of immunity which will evolve depends upon 
a complex interplay between three major classes of cell types: the antigen-presenting 
cells,  the  DTH  effector cells,  and  the  cells  in  the  regulatory suppressor cell  circuit 
(24).  The three major factors that have been identified so far which can significantly 
alter the normal interplay are:  (a)  the anatomical site where the initial  immunizing 
procedure occurs;  (b)  the  presence or absence of a  subset  of cells in  the suppressor 
circuit that are highly sensitive to CY; and (c) the nature and origin of the cell which 
presents the antigen. 
Summary 
Three  outcomes  pertinent  to  contact  sensitivity  (CS)  follow  immunization  with 
various  forms  of trinitrophenylated  (TNP)  substrates:  (a)  specific  immunological 
unresponsiveness for CS  is induced  when  immunization  favors activation of splenic 
suppressor  cells.  This  state  is  achieved  by  intravenous  injection  of trinitrophenyl- 
conjugated  to  various  types of cells,  such  as peritoneal  exudate  cells  (PEC).  (b)  A 
short-lived or evanescent form of CS is induced when immunization reduces activation 
of the suppressor circuit.  This can be achieved by subcutaneous immunization with 
trinitrophenyl conjugated to syngeneic PEC, by pretreatment with cyclophosphamide 
to diminish suppression before intravenous immunization, or by altering the mode of 
antigen presentation by using TNP-substrate that has undergone phagocytosis. (c) A 
long-lived  form of CS  is  induced  when  trinitrophenyl  is  presented  to  the  immune 
system on skin cells either by contact skin painting with reactive trinitrophenyl, or by 
subcutaneous,  or even intravenous  injection  of trinitrophenyl-conjugated  epidermal 
cells.  In fact, trinitrophenyl-conjugated  epidermal cells  induced  CS  even when  the 
suppressor circuit was activated by intravenous coadministration of TNP-PEC. This 374  EVANESCENT  VS.  LONG-LASTING  CONTACT  SENSITIVITY 
implies that  antigen presentation on epidermal cells induces sensitized cells that  are 
relatively resistant  to  suppression.  The  cell  type(s)  in  the  skin  that  are  primarily 
responsible for this potent  form  of antigen  presentation are most  likely Langerhans 
cells, because they can be concentrated by virtue of their Fc receptors and they are Ia 
positive. Thus,  both  the  anatomical  site  where  antigen  is  first  encountered  by  the 
immune  apparatus,  as  well  as  the  nature  of the  cells  which  present  the  antigen, 
determine whether a  CS response will ensue, as well as whether it will be evanescent 
or long-lasting. 
Received  for publication 9 August 1979. 
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